BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6390858)

  • 21. Cyclosporine and unresponsiveness to allografts induced by polyclonal antilymphocyte serum and donor-specific bone marrow.
    Monaco AP; Wood ML; Maki T; Hartner W; De Fazio S; Gozzo JJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):36-48. PubMed ID: 2968700
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
    Thomas JM; Carver FM; Burnett CM; Thomas FT
    Transplant Proc; 1981 Mar; 13(1 Pt 1):599-602. PubMed ID: 7022896
    [No Abstract]   [Full Text] [Related]  

  • 24. Total lymphoid irradiation in transplantation.
    Myburgh JA
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):118-21. PubMed ID: 3279604
    [No Abstract]   [Full Text] [Related]  

  • 25. Synergistic effects of cyclosporine and rabbit antithymocyte sera on suppression of the one-way allogeneic mixed lymphocyte response.
    Brady HR; Peters P; Cardella CJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):229-32. PubMed ID: 2966478
    [No Abstract]   [Full Text] [Related]  

  • 26. Effective and ineffective systems of in vitro testing for antilymphocyte globulin (ALG) potency: correlation of mixed agglutination and primate skin graft testing.
    Millington M; Thomas FT; Berry R; Thomas JM; Lee HM
    Surg Forum; 1977; 28():329-31. PubMed ID: 103222
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
    Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
    Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro studies on the mechanism of action of human antithymocyte globulin.
    Thomas JM; Thomas F; Williams E; Scott J
    Proc Clin Dial Transplant Forum; 1977; 7():141-7. PubMed ID: 98764
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine dosage requirements for rabbit skin allograft enhancement due to perioperative blood transfusion and cyclosporine synergy.
    Masendycz PJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2895-7. PubMed ID: 3551232
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of immunosuppression in long surviving (LS) monkey allograft recipients.
    Thomas J; Carver M; Cunningham P; Saldanha C; Thomas F
    Transplant Proc; 1989 Feb; 21(1 Pt 1):388-90. PubMed ID: 2650156
    [No Abstract]   [Full Text] [Related]  

  • 31. Low-dose azathioprine is synergistic with low-dose cyclosporine in rabbit skin allograft survival.
    Friedman AL; Schiffman G; Josephson AS; Coburger LE; Friedman EA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1270-1. PubMed ID: 3274317
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term skin allograft survival by combined therapy with suboptimal dose of cyclosporine and ribavirin.
    Jolley WB; Sharma B; Chami R; Ng C; Bullington R
    Transplant Proc; 1988 Aug; 20(4):703-6. PubMed ID: 3043841
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A brief course of cyclosporine A pretransplant reduces posttransplant cyclosporine A requirements in beagles and humans.
    Burke G; Esquenazi V; Milgrom M; Fuller L; Roth D; Olson L; Miller J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):478-80. PubMed ID: 3363650
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical factors in the quality control of antilymphocyte globulin (ALG).
    Thomas F; Thomas J; Millington G; Doane J; Mendez-Picon G; Lee HM
    Proc Clin Dial Transplant Forum; 1977; 7():134-40. PubMed ID: 98763
    [No Abstract]   [Full Text] [Related]  

  • 37. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract]   [Full Text] [Related]  

  • 38. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of skin allograft rejection by antilymphocytic serum pretreatment of the donor. Immunological preparation of the graft.
    Petrányi G; Szegedi G; Fekete B
    Acta Med Acad Sci Hung; 1971; 28(2):155-8. PubMed ID: 4948114
    [No Abstract]   [Full Text] [Related]  

  • 40. Aplastic anemia associated with dyskeratosis congenita treated with antilymphocyte globulin and cyclosporine: a case report.
    Huang HM; Yu WL; Huang YL; Hwang WS; Tsao CJ; Liu HS; Huang GC
    Chin Med J (Engl); 2005 May; 118(9):790-2. PubMed ID: 15899147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.